Chemotherapy Flashcards
Paclitaxel
Plant Alkaloid
Breast, pancreatic, lung, H/N
Peripheral neuropathy, milky appearance, skin rash
Dactinomycin
Antitumor Antibiotic
Brentuximab Vedotin
Monoclonal Antibody-targets CD30
Hodgkin Lymphoma; NHL
Infusion related reactions, peripheral neuropathy, myelosuppression
Doxorubicin
Antitumor Antibiotic
Breast; Lymphoma; sarcoma; liver;
cardiomyopathy, vesicant, anthracycline, max cumulative dose of 550mg/m2 (with Cytoxan may be reduced to 450mg/m2)
Testing prior: ECHO/MUGA
Ado-Trastuzumab emtansine
Monoclonal Antibody- targets Her 2
Breast
Infusion related reactions, hepatic toxicity (elevated LFT’s), pulmonary toxicity, altered LVEF, thrombocytopenia, bleeding
Testing: ECHO/Muga
Everolimus
mTOR inhibitor
Renal; breast; liver
Mucositis, cyp3A interactions
Aldesleukin (IL-2)
Biologic Therapy
Melanoma; renal
Capillary leak
Alemtuzumab
Monoclonal Antibody-targets CD52
Lymphoma or CLL
Severe lymphodepletion need prophylactic antibiotics.
HSR
Pemetrexed
Antimetabolite
lung
Folic acid, Vit B12 replacement
Dex for fluid retention.
Melphalan
Alkylating Agent
CLL, MM
High dose- severe mucositis (oral cryotherapy)
Amifostine
Not Chemo- chemoprotectant
Hypotension, N/V, Not Chemo
cytarabine
Antimetabolite
Leukemia
High dose (greater than 1gm/m2)-cerebellar toxicity and ocular (keratitis), myelosuppression
Testing: Cerebellar assessment
Darbopoietin alfa
Growth Factor
Avoid in curable cancers- risk of progression and hyper viscosity (stroke)
Pamidronate
Bisphosphonate
Renal toxicity
Used for hypercalcemia and to prevent bone loss, osteonecrosis of the jaw
Testing: Check kidney function prior and make sure do dental work prior
Nelarabine
Nucleoside metabolite inhibitor
Ofatumumab
Blocks CD20 MAB
Lymphoma
Infusion reaction; Hepatitis reactivation
Testing: Hepatitis panel
Arsenic Trioxide
Prolonged QTc, correct K and Mag
Testing: EKG
Asparginase
Asparagine specific activity ALL Allergic reaction Coagulopathies Pancreatitis
All Trans Retinoic Acid (ATRA)
Retinoic acid receptor
AML
Pulmonary syndrome that requires dex
Atezolizumab
PDL-1 inhibitor
Urothelial cancer; lung
Immune mediated reactions
Bevacizumab
Antiangiogenesis
Colon; ovary; brain; lung
High Bp, headaches, nose bleeds.
Poor wound healing, GI perforation- wait 4 weeks for surgery
Avelumab
Monoclonal antibody- Targets PDL-1
urothelial
Infusion related reactions, Immune mediated reactions
Azaciditine
Hypomethylating Agent
MDS; AML
In SQ form- skin reaction (2 shots), IV short stability, don’t hold dose for low bld ct
Carmustine
Nitrosourea
Brain; NHL; MM
Delayed pulmonary toxicity
Mixed in alcohol
Belinostat
H-DAC inhibitor
Nausea, vomiting, fever, prolonged QT
Bendamustine
Alkylating Agent
Lymphoma
HSR*, rash
Inotuzumab Ozogamycin
Monoclonal antibody Targets CD22
ALL
Infusion related reactions; LFT abnormalities
VOD/SOS, protect from light, no filters, myelosuppression
Bleomycin
Antitumor Antibiotic Lymphoma; testicular (germ cell) Pulmonary toxicity Fevers HSR* suggest test dose with lymphoma Testing: PFT
Blinatumomab
Bispecific T cell engager- CD 19»CD3
ALL
Cytokine release syndrome, neurologic symptoms
Brentuximab Vedotin
Monoclonal Antibody
Bortezomib
Proteosome Inhibitor/
MM
Peripheral neuropathy, reactivation of viral infection. Green tea interaction
Busulfan
Alkylating Agent
Leukemia
Seizures in high dose
Cabazitaxel
Plant Alkaloid
Prostate
Low blood counts
Irinotecan
Camptothecans
GI (colon; rectal and pancreatic); lung
Diarrhea - Imodium and cholinergic diarrhea- atropine
Testing: check UGT1A1 for metabolism
Capecitabine
Antimetabolite
GI (colon and rectal); breast
Prodrug of 5FU and can be used interchangeably, Hand foot syndrome
Prolonged INR
Carboplatin
Alkylator like (nm) Lung; breast; ovary; endometrial; esophageal; H/N AUC dosing Delayed HSR* (8-10th dose)
Carmustine
Lomustine
Nitrosourea
Brain
Cetuximab
Monoclonal Antibody- Targets EGFR
H/N; colon
HSR*, acne like rash
K-ras mutation doesn’t respond
Chlorambucil
Alkylating Agent
Cisplatin
Alkylator like (platinum)
Lung; testicular (germ cell); esophageal; H/N; cervical
N/V; peripheral neuropathy-ototoxicity. Also called CDDP
Testing: Renal (check BUN/Cr)
Cyclophosphamide
Alkylating Agent Breast; lymphoma; non malignancy Cystitis- mesna sometimes used to prevent especially in high dose Void often Secondary malignancies
Dacarbazine
Burning during peripheral infusion
Daratumumab
Anti-CD 38 MAB
MM
Infusion reaction (first dose can take 10 hours to infuse; Interference with cross-matching and red blood cell antibody screening: Type and screen patients prior to starting treatment. Inform blood banks that a patient has received DARZALEX
Dasatinib
Tyrosine kinase inhibitor- BCR/ABL (Philadelphia chromosome)
Pleural effusion
Daunorubicin
Antitumor Antibiotic anthracycline ALL; AML cardiomyopathy, vesicant, Testing prior: ECHO/MUGA
Docetaxel
Plant Alkaloid
Breast; lung; prostate; ovary; endometrial
Tearing, nail changes, fluid retention (give dex); peripheral neuropathy
Liposomal Doxorubicin
Antitumor Antibiotic
Breast; ovary; endometrial; MM
Hand foot rash; use cold to prevent the rash on hands and in mouth (avoid hot in mouth)HSR*
Testing: Check ECHO/Muga for LVEF
Durvalumab
Monoclonal antibody -Targets PD-L1
Urothelial; lung
Immune mediated toxicities